期刊
CELL STEM CELL
卷 19, 期 5, 页码 587-592出版社
CELL PRESS
DOI: 10.1016/j.stem.2016.10.013
关键词
-
资金
- Exploratory Research for Advanced Technology (ERATO) grant from the Japan Science and Technology Agency
- Leading Advanced Projects for medical innovation (LEAP) grant from AMED
- MEXT/JSPS KAKENHI [15K20948]
- Japan Insulin-Dependent Diabetes Mellitus Network
- California Institute for Regenerative Medicine [LA1-06917]
- Fannie and John Hertz Foundation
- U.S. National Science Foundation
- Davidson Institute for Talent Development
- Grants-in-Aid for Scientific Research [15K20948] Funding Source: KAKEN
Cell types more advanced in development than embryonic stem cells, such as EpiSCs, fail to contribute to chimeras when injected into pre-implantation-stage blastocysts, apparently because the injected cells undergo apoptosis. Here we show that transient promotion of cell survival through expression of the anti-apoptotic gene BCL2 enables EpiSCs and Sox17(+) endoderm progenitors to integrate into blastocysts and contribute to chimeric embryos. Upon injection into blastocyst, BCL2-expressing EpiSCs contributed to all bodily tissues in chimeric animals while Sox17(+) endoderm progenitors specifically contributed in a region-specific fashion to endodermal tissues. In addition, BCL2 expression enabled rat EpiSCs to contribute to mouse embryonic chimeras, thereby forming interspecies chimeras that could survive to adulthood. Our system therefore provides a method to overcome cellular compatibility issues that typically restrict chimera formation. Application of this type of approach could broaden the use of embryonic chimeras, including region-specific chimeras, for basic developmental biology research and regenerative medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据